Drymiotou, S.; Theodorou, E.; Rallis, K.S.; Nicolaides, M.; Sideris, M.
Molecular Biomarkers in Borderline Ovarian Tumors: Towards Personalized Treatment and Prognostic Assessment. Cancers 2025, 17, 545.
https://doi.org/10.3390/cancers17030545
AMA Style
Drymiotou S, Theodorou E, Rallis KS, Nicolaides M, Sideris M.
Molecular Biomarkers in Borderline Ovarian Tumors: Towards Personalized Treatment and Prognostic Assessment. Cancers. 2025; 17(3):545.
https://doi.org/10.3390/cancers17030545
Chicago/Turabian Style
Drymiotou, Stefania, Efthymia Theodorou, Kathrine Sofia Rallis, Marios Nicolaides, and Michail Sideris.
2025. "Molecular Biomarkers in Borderline Ovarian Tumors: Towards Personalized Treatment and Prognostic Assessment" Cancers 17, no. 3: 545.
https://doi.org/10.3390/cancers17030545
APA Style
Drymiotou, S., Theodorou, E., Rallis, K. S., Nicolaides, M., & Sideris, M.
(2025). Molecular Biomarkers in Borderline Ovarian Tumors: Towards Personalized Treatment and Prognostic Assessment. Cancers, 17(3), 545.
https://doi.org/10.3390/cancers17030545